BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28526171)

  • 1. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
    Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
    Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
    Storey S; Brown J; Foley A; Newkirk E; Powers J; Barger J; Paige K
    Am J Infect Control; 2016 Jun; 44(6):636-41. PubMed ID: 27240799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
    Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
    Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
    Marty Cooney R; Manickam N; Becherer P; Harmon LS; Gregg L; Farkas Z; Shea LM; Parekh P; Murphy J; Shade W
    Br J Nurs; 2020 Jan; 29(2):S24-S26. PubMed ID: 31972108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
    BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
    Kim E; Lee H
    J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections.
    Quach C; Milstone AM; PerpĂȘte C; Bonenfant M; Moore DL; Perreault T
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):158-63. PubMed ID: 24442078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections.
    Dixon JM; Carver RL
    Am J Infect Control; 2010 Dec; 38(10):817-21. PubMed ID: 21093698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
    Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
    Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
    Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
    J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials.
    Afonso E; Blot K; Blot S
    Euro Surveill; 2016 Nov; 21(46):. PubMed ID: 27918269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?
    Buetti N; Ruckly S; Schwebel C; Mimoz O; Souweine B; Lucet JC; Timsit JF
    Crit Care; 2020 Jul; 24(1):458. PubMed ID: 32703235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
    Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
    Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections.
    Shah HN; Schwartz JL; Luna G; Cullen DL
    Crit Care Nurs Q; 2016; 39(1):42-50. PubMed ID: 26633158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.